729 related articles for article (PubMed ID: 9029725)
1. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
2. Structure of a cytochrome P450-redox partner electron-transfer complex.
Sevrioukova IF; Li H; Zhang H; Peterson JA; Poulos TL
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1863-8. PubMed ID: 10051560
[TBL] [Abstract][Full Text] [Related]
3. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
4. P450BM-3: reduction by NADPH and sodium dithionite.
Peterson JA; Boddupalli SS
Arch Biochem Biophys; 1992 May; 294(2):654-61. PubMed ID: 1567220
[TBL] [Abstract][Full Text] [Related]
5. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
[TBL] [Abstract][Full Text] [Related]
6. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
Sevrioukova I; Truan G; Peterson JA
Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
[TBL] [Abstract][Full Text] [Related]
7. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
Jenkins CM; Waterman MR
Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
[TBL] [Abstract][Full Text] [Related]
8. The domain architecture of cytochrome P450BM-3.
Govindaraj S; Poulos TL
J Biol Chem; 1997 Mar; 272(12):7915-21. PubMed ID: 9065459
[TBL] [Abstract][Full Text] [Related]
9. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
10. Association of cytochromes P450 with their reductases: opposite sign of the electrostatic interactions in P450BM-3 as compared with the microsomal 2B4 system.
Davydov DR; Kariakin AA; Petushkova NA; Peterson JA
Biochemistry; 2000 May; 39(21):6489-97. PubMed ID: 10828964
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
13. Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities.
Jenkins CM; Waterman MR
J Biol Chem; 1994 Nov; 269(44):27401-8. PubMed ID: 7961651
[TBL] [Abstract][Full Text] [Related]
14. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
[TBL] [Abstract][Full Text] [Related]
17. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
18. Complexation of membrane-bound enzyme systems.
Müller-Enoch D; Gruler H
Z Naturforsch C J Biosci; 2000; 55(9-10):747-52. PubMed ID: 11098825
[TBL] [Abstract][Full Text] [Related]
19. A three-dimensional model of aromatase cytochrome P450.
Graham-Lorence S; Amarneh B; White RE; Peterson JA; Simpson ER
Protein Sci; 1995 Jun; 4(6):1065-80. PubMed ID: 7549871
[TBL] [Abstract][Full Text] [Related]
20. High-resolution studies of hydride transfer in the ferredoxin:NADP
Kean KM; Carpenter RA; Pandini V; Zanetti G; Hall AR; Faber R; Aliverti A; Karplus PA
FEBS J; 2017 Oct; 284(19):3302-3319. PubMed ID: 28783258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
